Lumen, an Israeli med-tech company that manufactures a device to check metabolism, raised $62 million in a Series B funding led by Pitango Venture Capital. Participating investors also included Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital, and Disruptive VC.
Lumen connects with health data platforms including Apple Healthkit, Google Fit and Garmin.
“Until now, studying metabolism with the standard equipment was challenging for both researchers and participants,” co-founder and chief scientist Merav Mor said. “The data collection was minimal and would require participants to come to a clinic for each measurement and a practitioner to analyze the results. Now researchers can easily collect multiple data points from participants and build more complex research protocols that unveil new physiological findings.”
“Understanding the impact of nutrition, exercise, sleep, and stress on your metabolism is key to reaching your health goals. One of the things we’re most excited about is enabling people to take care of the ‘engine of the body’, which is our metabolism,” said Daniel Tal, CEO and co-founder.
